XML 37 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Shareholders' Equity
12 Months Ended
Dec. 31, 2020
Shareholders' Equity  
Shareholders' Equity

Note 11—Shareholders’ Equity

Common Stock

As of December 31, 2020, we had reserved shares of common stock under our equity plans as follows:

Options granted and outstanding

    

11,938,528

Options available for future grant

 

4,089,584

Common stock warrants

 

243,115

Total shares reserved

 

16,271,227

Securities Offerings – In August 2020, we sold 6.9 million shares of our common stock at a public offering price of $14.50 per share. After deducting underwriter discounts and offering expenses, we received net proceeds from the transaction of $93.7 million.

In December 2019, we sold 4.4 million shares of our common stock at a public offering price of $13.10 per share. After deducting underwriter discounts and offering expense, we received net proceeds from the transaction of $54.2 million.

At the Market Sales Agreement – On March 1, 2021, we entered into a sales agreement to sell shares of our common stock having an aggregate offering price of up to $150.0 million, from time to time, through an “at the market” equity offering program.

Warrants

In connection with various previously outstanding debt agreements we have issued warrants to purchase shares of our common stock as follows:

Outstanding At

    

    

December 31, 2020

Expiration Date

Exercise Price

43,115

May 18, 2023

$

9.94

200,000

April 12, 2023

$

23.00